Table 2 Averages for metabolic variables during CLT and TT in the YMD-CHO, YMD-F, and control-CHO trials

0.76 ± 0.18*^,#,

0.70 ± 0.51*^,#

0.71 ± 0.17*

0.36 ± 0.32

0.64 ± 0.13

0.39 ± 0.29

1.06 ± 0.34

2.71 ± 0.75^#

1.07 ± 0.32

3.28 ± 0.76*

1.16 ± 0.19

2.91 ± 0.73

2.39 ± 0.32*^,#

3.56 ± 0.71*^,#

2.30 ± 0.17

3.34 ± 0.47*

2.22 ± 0.25

3.10 ± 0.39

1.93 ± 0.24

3.15 ± 0.45*

1.87 ± 0.12

3.13 ± 0.41*

1.84 ± 0.19

2.87 ± 0.35

19.8 ± 2.7

21.5 ± 4.2

20.9 ± 2.6

22.3 ± 2.5

21.2 ± 2.3

23.4 ± 2.8

0.81 ± 0.02*

0.89 ± 0.08*^,#

0.81 ± 0.03*

0.94 ± 0.06

0.83 ± 0.02

0.93 ± 0.06

123 ± 10

161 ± 14*

119 ± 12

160 ± 15*

122 ± 15

158 ± 17